Schedule 13D ownership disclosure

TiGenix NV

Security class unavailable · CUSIP: 88675R109

Event date: 2018-01-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-18-010089
Form type
SC 13D
Filer
TAKEDA PHARMACEUTICAL CO LTD
CIK
CIK 1395064
Filed
Jan 12, 2018
Reporting period
Jan 04, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub